These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6420143)

  • 1. Respiratory infection of cyclophosphamide-treated mice with Pseudomonas aeruginosa.
    Rowatt JD; Hill JO; Lundgren DL
    Exp Lung Res; 1983 Dec; 5(4):305-16. PubMed ID: 6420143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of lung infections caused by Pseudomonas aeruginosa in mice treated with cyclophosphamide.
    Mayer P; Walzl H
    Infection; 1983; 11(2):87-96. PubMed ID: 6408008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic
    Matsumoto T; Fujita M; Hirano R; Uchino J; Tajiri Y; Fukuyama S; Morimoto Y; Watanabe K
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2321-2327. PubMed ID: 27703342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary clearance of Pseudomonas aeruginosa.
    Southern PM; Mays BB; Pierce AK; Sanford JP
    J Lab Clin Med; 1970 Oct; 76(4):548-59. PubMed ID: 4989781
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas aeruginosa infection in mice after treatment with cyclophosphamide.
    Grogan JB
    Arch Surg; 1975 Dec; 110(12):1473-6. PubMed ID: 812454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis.
    Kipnis E; Sawa T; Wiener-Kronish J
    Med Mal Infect; 2006 Feb; 36(2):78-91. PubMed ID: 16427231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
    Amin R; Lam M; Dupuis A; Ratjen F
    Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pulmonary bactericidal capacity of mice and rats aganist strains of Pseudomonas aeruginosa.
    Southern PM; Pierce AK; Sanford JP
    Appl Microbiol; 1971 Feb; 21(2):377-8. PubMed ID: 4994356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
    Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
    Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM
    Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.
    Wölbeling F; Munder A; Kerber-Momot T; Neumann D; Hennig C; Hansen G; Tümmler B; Baumann U
    Immunobiology; 2011 Aug; 216(8):901-8. PubMed ID: 21497410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E; Thalhammer GH; Zach MS
    Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botryomycosis associated with Pseudomonas aeruginosa in the nasopharynx of a cow.
    Thompson PN; Van der Lugt JJ; Olivier-Carstens A
    Vet Rec; 2001 Oct; 149(16):495-6. PubMed ID: 11700932
    [No Abstract]   [Full Text] [Related]  

  • 18. NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection.
    Wesselkamper SC; Eppert BL; Motz GT; Lau GW; Hassett DJ; Borchers MT
    J Immunol; 2008 Oct; 181(8):5481-9. PubMed ID: 18832705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection.
    Lorè NI; Veraldi N; Riva C; Sipione B; Spagnuolo L; De Fino I; Melessike M; Calzi E; Bragonzi A; Naggi A; Cigana C
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Pseudomonas virulence using mammalian models: acute infection model.
    Munder A; Tümmler B
    Methods Mol Biol; 2014; 1149():773-91. PubMed ID: 24818949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.